Prokidney Corp is a late-clinical-stage biotechnology company developing a first-in-class autologous cell therapy intended to preserve kidney function in patients with advanced chronic kidney disease and diabetes. The company serves patients with moderate to severe CKD and type 2 diabetes.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.